Neuland Laboratories Ltd.
BSE: 524558 | Sector: Health care |
NSE: NEULANDLAB | ISIN Code: INE794A01010 |
BSE 00:00 | 24 Apr | Neuland Laboratories Ltd |
NSE 05:30 | 01 Jan | Neuland Laboratories Ltd |
OPEN | 395.20 |
PREVIOUS CLOSE | 394.30 |
VOLUME | 1410 |
52-Week high | 753.60 |
52-Week low | 247.30 |
P/E | 16.13 |
Mkt Cap.(Rs cr) | 516 |
Buy Price | 393.00 |
Buy Qty | 20.00 |
Sell Price | 415.00 |
Sell Qty | 25.00 |
Neuland Laboratories Ltd. (NEULANDLAB) - Announcements
-
Neuland Laboratories Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
23/04/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Compliances- Certificate Under Regulation 40(9) Of SEBI(LODR) Regulations 2015
21/04/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Statement Of Investor Complaints For The Quarter Ended March 2020
20/04/2020 | bse
-
Neuland Laboratories Ltd Shareholding for the Period Ended March 31 2020
17/04/2020 | bse
-
Neuland Laboratories Ltd Compliances- Compliance Certificate For The Period Ended March 31 2020
17/04/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Clarification On Share Price Movement
10/04/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Closure of Trading Window
31/03/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Credit Rating
20/03/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
19/03/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
12/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
11/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
11/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Corporate Action-Board approves Dividend
11/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Outcome Of The Board Meeting - Un-Audited Standalone & Consolidated Financial Results For Quarter En
11/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd General Updates
07/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Board Meeting Update- Record Date For Payment Of Interim Dividend For FY 2019-20 Subject To Approva
04/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Corporate Action-Board to consider Dividend
04/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Corporate Action-Board to consider Dividend
04/02/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011
27/01/2020 | bse |
Downlaod PDF
-
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Meeting Updates
24/01/2020 | bse |
Downlaod PDF
Quick Links for Neuland Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices